JB Chemicals & Pharmaceuticals Limited

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 31 March 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-16

Stock price
₹2408.90
Market cap
38,455 Cr
Stock P/E
54.5
P/B
9.25
Dividend yield
0.8%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales896 Cr882 Cr845 Cr862 Cr1,004 Cr1,001 Cr963 Cr949 Cr1,094 Cr1,085 Cr1,065 Cr904 Cr
Operating expenses (approx.)664 Cr638 Cr621 Cr664 Cr724 Cr730 Cr709 Cr723 Cr793 Cr775 Cr769 Cr703 Cr
EBITDA232 Cr244 Cr223 Cr198 Cr280 Cr271 Cr255 Cr226 Cr301 Cr310 Cr296 Cr201 Cr
OPM %25.9%27.6%26.4%23.0%27.9%27.0%26.4%23.8%27.5%28.5%27.8%22.2%
Other income6 Cr8 Cr7 Cr17 Cr6 Cr10 Cr8 Cr14 Cr15 Cr15 Cr18 Cr12 Cr
Interest12 Cr10 Cr12 Cr9 Cr6 Cr2 Cr3 Cr1 Cr1 Cr1 Cr2 Cr1 Cr
Depreciation31 Cr32 Cr34 Cr41 Cr41 Cr42 Cr42 Cr46 Cr43 Cr44 Cr45 Cr50 Cr
Profit before tax194 Cr209 Cr184 Cr165 Cr240 Cr237 Cr218 Cr193 Cr272 Cr279 Cr267 Cr135 Cr
Tax %26.8%27.8%27.4%23.4%26.3%26.2%25.5%24.5%25.5%25.6%25.8%24.7%
Net profit142 Cr151 Cr134 Cr126 Cr177 Cr175 Cr162 Cr146 Cr202 Cr208 Cr198 Cr101 Cr
EPS (₹)₹18.39₹9.72₹8.62₹8.22₹11.39₹11.24₹10.46₹9.36₹12.99₹13.29₹12.63₹6.35

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,643 Cr1,775 Cr2,043 Cr2,424 Cr3,149 Cr3,484 Cr3,918 Cr4,148 CrSign in for TTM
Operating expenses (approx.)1,338 Cr1,397 Cr1,482 Cr1,881 Cr2,454 Cr2,587 Cr2,886 Cr3,040 CrSign in for TTM
EBITDA305 Cr378 Cr560 Cr543 Cr696 Cr897 Cr1,032 Cr1,107 CrSign in for TTM
OPM %18.6%21.3%27.4%22.4%22.1%25.7%26.3%26.7%Sign in for TTM
Other income41 Cr51 Cr112 Cr39 Cr10 Cr37 Cr38 Cr60 CrSign in for TTM
Interest4 Cr3 Cr7 Cr5 Cr36 Cr44 Cr12 Cr6 CrSign in for TTM
Depreciation56 Cr66 Cr69 Cr73 Cr114 Cr138 Cr171 Cr183 CrSign in for TTM
Profit before tax287 Cr349 Cr597 Cr505 Cr555 Cr752 Cr887 Cr952 CrSign in for TTM
Tax %32.4%21.9%24.9%23.5%26.2%26.5%25.7%25.5%Sign in for TTM
Net profit194 Cr272 Cr449 Cr386 Cr410 Cr553 Cr660 Cr709 CrSign in for TTM
EPS (₹)₹23.54₹34.20₹57.96₹49.86₹53.00₹35.66₹42.45₹45.16Sign in for TTM
Dividend payout %———33.0%31.1%28.4%35.9%44.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr15 Cr15 Cr15 Cr15 Cr16 Cr16 Cr16 Cr
Reserves1,464 Cr1,420 Cr1,794 Cr2,119 Cr2,465 Cr2,908 Cr3,418 Cr4,143 Cr
Borrowings26 Cr32 Cr33 Cr26 Cr548 Cr357 Cr14 Cr—
Other liabilities282 Cr344 Cr392 Cr442 Cr525 Cr714 Cr827 Cr809 Cr
Total liabilities1,791 Cr1,814 Cr2,238 Cr2,607 Cr3,554 Cr3,994 Cr4,274 Cr4,969 Cr
Fixed assets (net)544 Cr568 Cr544 Cr519 Cr532 Cr572 Cr610 Cr612 Cr
CWIP15 Cr16 Cr26 Cr14 Cr44 Cr63 Cr47 Cr61 Cr
Investments457 Cr403 Cr678 Cr13 Cr206 Cr388 Cr345 Cr765 Cr
Loans & advances1 Cr4 Cr2 Cr1 Cr1 Cr0.70 Cr0.55 Cr0.54 Cr
Inventories244 Cr275 Cr347 Cr410 Cr430 Cr503 Cr529 Cr683 Cr
Trade receivables309 Cr345 Cr389 Cr556 Cr576 Cr687 Cr815 Cr781 Cr
Cash & bank35 Cr29 Cr29 Cr57 Cr77 Cr88 Cr115 Cr110 Cr
Other assets185 Cr173 Cr223 Cr1,038 Cr1,687 Cr1,693 Cr1,812 Cr1,956 Cr
Total assets1,791 Cr1,814 Cr2,238 Cr2,607 Cr3,554 Cr3,994 Cr4,274 Cr4,969 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———170 Cr626 Cr801 Cr902 Cr704 Cr
Cash from investing———2 Cr-962 Cr-404 Cr-296 Cr-586 Cr
Cash from financing———-138 Cr357 Cr-385 Cr-580 Cr-123 Cr
Net cash flow———34 Cr20 Cr11 Cr27 Cr-5 Cr
Free cash flow (OCF − Capex)———-537 Cr-139 Cr539 Cr782 Cr704 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %19.7%24.5%33.4%23.9%19.5%24.3%26.1%23.0%
ROE %13.1%19.0%24.8%18.1%16.5%-0.5%0.2%17.1%
Debtor days6971698367727669
Inventory days196222233248200225235273
Days payable66100125136111159182156
Cash conversion cycle198193177196156137128185
Debt / equity0.020.020.020.010.220.120.0040—
Current ratio4.323.434.503.322.802.153.064.98
Net debt / EBITDA0.000.000.000.000.680.30-0.10-0.10

Compare with peers

Loading peers…